End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.73 CNY | +1.10% | +3.00% | -23.42% |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-23.42% | 374M | - | ||
-1.34% | 12.58B | B+ | ||
-1.64% | 8.51B | B- | ||
+0.09% | 5.29B | B | ||
+21.34% | 5.16B | C | ||
-0.09% | 4.55B | C | ||
-54.45% | 3.04B | D+ | ||
+20.02% | 3B | - | - | |
+29.57% | 2.17B | C | ||
-2.45% | 1.92B | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688338 Stock
- Ratings Beijing Succeeder Technology Inc.